ScholarWorks@Sookmyung Women's University: Kim, Hyun Ah

Detailed Information

Kim, Hyun Ah (김현아)

약학대학 (약학부)

Research Area

Tel
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

statin:6||Diabetes mellitus:5||Diabetes Mellitus:4||diabetes mellitus:4||HMGCoA reductase inhibitor:3||smoking:3||angiotensinconverting enzyme inhibitors:3||education:2||drug interactions:2||ACEI:2||Hemoglobin A1c:2||irbesartan:2||HydroxymethylglutarylCoA reductase inhibitors:2||medication:2||Hypoglycemia:2||dyslipidemia:2||hypoglycemia:2||hepatotoxicity:2||antiinfective agents:2||Blood Glucose:2||hydroxymethylglutarylCoA reductase inhibitors:2||ARB:2||drug interaction:2||Delirium:1||Delivery of Health Care:1||Dexmedetomidine:1||Diabetes complications:1||Diabetes education:1||Diabetic ketoacidosis:1||Elderly:1||Electronic health records:1||Examination:1||Exercise:1||Glycated Hemoglobin (HbA1c):1||Glycemic Control:1||HMGCoA:1||HMGCoA reductase inhibitor (statin):1||Haloperidol:1||HbA1c:1||HbA1c Variability Score:1||Health Personnel:1||Health educators:1||Healthcare:1||Heart failure:1||Hemoglobin A:1||Hypercholesterolaemia:1||IMRAD:1||Innovative CBT item types:1||Insulin:1||Insulin resistance:1||Introductory pharmacy practice experience:1||KAERS:1||Korean clinical trials:1||Korean traditional:1||Koreans:1||LDL:1||LDLcholesterol:1||Licensure:1||Medicine:1||Mobile phones:1||MultidrugResistant Acinetobacter baumannii (MDRAB):1||Nurses:1||Obese:1||Objective structured clinical examination:1||Orlistat:1||Overweight:1||Pharmacists:1||Pharmacy students:1||Quality of Health Care:1||Remote consultation:1||Respiratory function tests:1||SGLT2i:1||Sarcopenia:1||Sodium&:1||Sodiumglucose transporter 2 inhibitors:1||Stroke:1||Sulfonylurea compounds:1||TNFα inhibitors:1||TSH:1||Telecommunications:1||Telemedicine:1||Type 2:1||Underutilization:1||Vitamin D deficiency:1||Warfarin:1||Wearable Electronic Devices:1||Weight:1||acipimox:1||acute generalized exanthematous pustulosis:1||adherence:1||adverse drug reaction reporting:1||adverse event:1||adverse events:1||adverse reactions:1||albuminuria:1||aminotransferase elevation:1||angioedema:1||angiotensin II receptor blocker:1||angiotensin II receptor blockers:1||angiotensin receptor antagonists:1||antituberculosis:1||appropriate medication:1||barriers:1||caloric agents:1||candersartan:1||cardiovascular outcomes:1||case review:1||casecrossover design:1||cellular phone:1||chinese traditional:1||cholesterol:1||chronic kidney disease:1||clinical trials database:1||communication:1||communication with doctors:1||community pharmacists:1||consumer health:1||costeffectiveness:1||dapagliflozin:1||dextrose:1||diabetes:1||difficult disease on counseling:1||dipeptidyl peptidase 4 inhibitors:1||dispensing prescription:1||drug administration rate:1||drug hypersensitivity syndrome:1||drug utilization review:1||drugdrug interaction:1||drugdrug interactions:1||drugrelated side effects:1||dyslipidaemia:1||dyslipidemias:1||electronic medical record:1||emergency department:1||emergency service:1||erlotinib:1||euthyroid:1||ezetimibe:1||fenofibrate:1||fracture:1||gefitinib:1||glomerular filtration rate:1||glucose:1||glucose cotransporter&:1||glycosylated:1||hand strength:1||healthcare:1||heavy:1||home care and ehealth:1||home health:1||hospital:1||hypercholesterolemia:1||hyperglycemia:1||hypertriglyceridaemia:1||hypertriglyceridemia:1||hypothyroidism:1||immunosuppression:1||injections:1||liver failure:1||losartan:1||medication reconciliation:1||medicine:1||metals:1||mobile health:1||moxifloxacin:1||muscle strength:1||networks:1||nonsmall cell lung cancer:1||nutrition:1||older adults:1||older people:1||omega3 fatty acids:1||osteoporosis:1||parenteral nutrition:1||patient selfcare:1||perceptions:1||personal health records:1||pharmaceutical services:1||pharmacists&apos:1||pharmacodynamics:1||pharmacokinetics:1||pharmacy school:1||pneumonia:1||postmarketing surveillance:1||potentially inappropriate medication:1||potentially inappropriate medications:1||prediabetes:1||proton pump inhibitor:1||realworld data:1||realworld evidence:1||rheumatoid arthritis:1||satisfaction:1||side effects:1||sitagliptin:1||standards:1||statins:1||sulfonylurea compounds:1||survey:1||target achievement rate:1||telemedicine:1||thiazolidinedione:1||toxicity:1||treatment gap:1||type 2 diabetes:1||#160:1||uric acid:1||#8211:1||2:1||25hydroxyvitamin D:1||6year degree program:1||Acute myocardial infarction:1||Advanced pharmacy practice experience:1||Airway obstruction:1||American Heart Association:1||Antipsychotic Agents:1||Atrial fibrillation:1||Atrial flutter:1||Blood glucose:1||Cardiovascular Disease:1||Cerebrovascular disease:1||Clinical data mart:1||Clinical data warehouse:1||ClinicalTrials knowledge DB:1||Cohort studies:1||Competency assessment:1||Computerbased test:1||Crohn’s disease:1||DRESS syndrome:1||

STATISTICS: Total View :5,679,531; Today View :6,374

RSS_1.0 RSS_2.0 ATOM_1.0

Sookmyung Women's University. Cheongpa-ro 47-gil 100 (Cheongpa-dong 2ga), Yongsan-gu, Seoul, 04310, Korea 02-710-9127

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE